000			01839 a2200529 4500
005			20250513235308.0
264		0	_c20010607
008			200106s 0 0 eng d
022			_a0014-4886
024	7		_a10.1006/exnr.2001.7647 _2doi
040			_aNLM _beng _cNLM
100	1		_aPirker, W
245	0	0	_aCoadministration of (-)-OSU6162 with l-DOPA normalizes preproenkephalin mRNA expression in the sensorimotor striatum of primates with unilateral 6-OHDA lesions. _h[electronic resource]
260			_bExperimental neurology _cMay 2001
300			_a122-34 p. _bdigital
500			_aPublication Type: Journal Article; Research Support, Non-U.S. Gov't
650	0	4	_aAnimals
650	0	4	_aAutoradiography
650	0	4	_aCallithrix
650	0	4	_aCaudate Nucleus _xmetabolism
650	0	4	_aCorpus Striatum _xdrug effects
650	0	4	_aDisease Models, Animal
650	0	4	_aDopamine Agents _xadministration & dosage
650	0	4	_aDrug Administration Schedule
650	0	4	_aDrug Therapy, Combination
650	0	4	_aEnkephalins _xgenetics
650	0	4	_aFemale
650	0	4	_aIn Situ Hybridization
650	0	4	_aInjections, Subcutaneous
650	0	4	_aLevodopa _xadministration & dosage
650	0	4	_aLigands
650	0	4	_aMale
650	0	4	_aOxidopamine
650	0	4	_aParkinson Disease, Secondary _xchemically induced
650	0	4	_aPiperidines _xadministration & dosage
650	0	4	_aProtein Precursors _xgenetics
650	0	4	_aPutamen _xmetabolism
650	0	4	_aRNA, Messenger _xmetabolism
650	0	4	_aTritium
700	1		_aTedroff, J
700	1		_aPontén, H
700	1		_aGunne, L
700	1		_aAndrén, P E
700	1		_aHurd, Y L
773	0		_tExperimental neurology _gvol. 169 _gno. 1 _gp. 122-34
856	4	0	_uhttps://doi.org/10.1006/exnr.2001.7647 _zAvailable from publisher's website
999			_c11247040 _d11247040